• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENCORE MEDICAL L.P. BIOLOX DELTA HIP; HEAD, FEMORAL, CERAMIC, BILOX DELTA OPTION HEAD, 32MM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENCORE MEDICAL L.P. BIOLOX DELTA HIP; HEAD, FEMORAL, CERAMIC, BILOX DELTA OPTION HEAD, 32MM Back to Search Results
Model Number 400-04-320
Health Effect - Clinical Code Post Operative Wound Infection (2446)
Date of Event 03/25/2018
Type of Reportable Event Serious Injury
Event or Problem Description
Second revision surgery - due to the hip being revised for an irrigation and debridement.The surgeon changed the head and sleeve.
 
Additional Manufacturer Narrative
The reason for this revision surgery was due to an irrigation and debridement.The previous surgery and the revision detailed in this investigation occurred 32 days apart.There is no information in this complaint about any patient injuries, activities, or accidents that may have contributed to the need for this revision surgery.There are no reported pre-existing patient health conditions.The healthcare professional indicated there was a delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The device was disposed of at the hospital and not made available to djo surgical for examination.A review of the implant device history records (dhr), shows that the reported component used in the previous surgery met design and manufacturing requirements.There were no non-conforming material reports (ncmrs) associated with the product that may have contributed to the reported event.The device was verified to have gone through an acceptable sterilization process and was within its expiration date at the time of use during the previous surgery.Customer complaint history of the reported device showed no present trends or on-going issues that are in need of review.The root cause of this complaint was a revision surgery for irrigation and debridement.There were no findings during this investigation that indicate that the reported device was defective.There are multiple factors that may contribute to an event that are outside of the control of djo surgical.Inventory containment is not required as there are no indications of a product or process issue affecting implant safety or effectiveness.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOLOX DELTA HIP
Common Device Name
HEAD, FEMORAL, CERAMIC, BILOX DELTA OPTION HEAD, 32MM
Manufacturer (Section D)
ENCORE MEDICAL L.P.
9800 metric blvd
austin TX 78758 5445
MDR Report Key7386040
Report Number1644408-2018-00282
Device Sequence Number1173052
Product Code LZO
UDI-Device Identifier00888912076241
UDI-Public(01)00888912076241
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
K082844
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2018
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 04/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/26/2021
Device Model Number400-04-320
Device Catalogue Number400-04-320
Device Lot Number882B1017
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 03/25/2018
Supplement Date Received by Manufacturer04/19/2018
Initial Report FDA Received Date03/30/2018
Supplement Report FDA Received Date04/20/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
400-05-000, LOT 886B1099; 400-05-000, LOT 886B1099
Outcome Attributed to Adverse Event Required Intervention;
Patient Age58 YR
-
-